For a comprehensive understanding of the role of plasma PD-L1 in overall survival and prognosis of GBM, future studies should compare the pre-surgery and post-surgery groups with a large sample size so that patient groups can be stratified and an optimized therapy regimen be devised. This evidence concerns the gene CD274 and glioblastoma.